Ginsenoside Re, a main phytosterol of Panax ginseng, activates cardiac potassium channels via a nongenomic pathway of sex hormones

Molecular Pharmacology

Volumn 70, Issue 6, 2006, Pages 1916-1924

  Furukawa, Tetsushi ^a,d   Bai, Chang Xi ^a   Kaihara, Asami ^a   Ozaki, Eri ^a   Kawano, Takashi ^b   Nakaya, Yutaka ^b   Awais, Muhammad ^c   Sato, Moritoshi ^c   Umezawa, Yoshio ^c   Kurokawa, Junko ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CALCIUM; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN RECEPTOR ALPHA; GINSENG EXTRACT; GINSENOSIDE RE; PANAXADIOL; PHOSPHATIDYLINOSITOL 3 KINASE; PHYTOSTEROL; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; PROGESTERONE RECEPTOR; PROTEIN KINASE B; SEX HORMONE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM BONE LEVEL; CELL PROLIFERATION; CELL STRAIN LNCAP; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG INHIBITION; DRUG RECEPTOR BINDING; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GINSENG; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL;

ANIMALS; CELLS, CULTURED; ENZYME ACTIVATION; ESTROGEN RECEPTOR ALPHA; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GINSENOSIDES; GUINEA PIGS; HEART; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PANAX; PHOSPHORYLATION; POTASSIUM CHANNELS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ANDROGEN; RECEPTORS, PROGESTERONE;

EID: 33751119582     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.028134     Document Type: Article

References (40)

1. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, and Fukami Y (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595.
2. Attele AS, Wu JA, and Yuan C-S (1999) Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 58:1685-1693.
3. Awais M, Sato M, Sasaki K, and Umezawa Y (2004) A genetically encoded fluorescent indicator capable of discriminating estrogen agonists from antagonists in living cells. Anal Chem 76:2181-2186.
4. Awais M, Sato M, Lee X, and Umezawa Y (2006) A fluorescent indicator to visualize activities of the androgen receptor ligands in single living cells. Angew Chem Int 45:2707-2712.
5. Bai C-X (1993) Further research on the protective effects of ginsenoside Re on myocardial ischemia/reperfusion injury in rats. Master degree's thesis.
6. Bai C-X, Kurokawa J, Tamagawa M, Nakaya H, and Furukawa T (2005a) Nontranscriptional regulation of cardiac repolarization currents by testosterone. Circulation 112:1701-1710.
7. + current in cardiac myocytes. Circ Res 96:64-72.
8. Bai C-X, Sunami A, Namiki T, Sawanobori T, and Furukawa T (2003) Electrophysiological effects of ginseng and ginsenoside Re in guinea pig ventricular myocytes. Eur J Pharmacol 476:35-44.
9. 2+ current by ginsenoside Re, an ingredient of Panax ginseng, in guinea-pig cardiomyocytes. Br J Pharmacol 142:567-575.
10. Baron S, Manin M, Beaudoin C, Leotoing L, Communal Y, Veyssiere G, and Morel L (2004) Androgen receptor mediates non-genomic activation of phosphatidylinositol 3-OH kinase in androgen-sensitive epithelial cells. J Biol Chem 279:14579-14586.
11. Barrett-Connor E, Grady D, and Stefanick ML (2005) The rise and fall of menopausal hormone therapy. Annu Rev Public Health 26:115-140.
12. Boyer M, Poujol N, Margeat E, and Royer CA (2000) Quantitative characterization of the interaction between purified human estrogen receptor alpha and DNA using fluorescence anisotropy. Nucleic Acids Res 28:2494-2502.
13. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, and Carlquist M (1997) Molecular basis of agonism and antagonism in the oestrogen receptor. Nature (Lond) 389:753-758.
14. Duda RB, Zhong Y, Navas V, Li MZ, Toy BR, and Alavarez JG (1999) American ginseng and breast cancer therapeutic agents synergistically inhibit MCF-7 breast cancer cell growth. J Surg Oncol 72:230-239.
15. Gillis CN (1997) Panax ginseng pharmacology: a nitric oxide link? Biochem Pharmacol 54:1-8.
16. Goldman P (2001) Herbal medicines today and the roots of modern pharmacology. Ann Intern Med 135:594-600.
17. Goligorsky MS, Li H, Brodsky S, and Chen J (2002) Relationships between caveolae and eNOS: everything in proximity and the proximity of everything. Am J Physiol 283:F1-F10.
18. Hartley DE, Elsabagh S, and File SE (2004) Gincosan (a combination of Ginkgo biloba and Panax ginseng): the effects on mood and cognition of 6 and 12 weeks' treatment in post-menopausal women. Nutr Neurosci 7:325-333.
19. Hasenson M, Hartley-Asp B, Kihlfors C, Lundin A, Gustafsson JA, and Pousette A (1985) Effect of hormones on growth and ATP content of a human prostatic carcinoma cell line, LNCaP-r. Prostate 7:183-194.
20. Hijazi RA and Cunningham GR (2005) Andropause: is androgen replacement therapy indicated for the aging male? Annu Rev Med 56:117-137.
21. Kim OS, Choi JH, Soung YH, Lee SH, Lee JH, Ha JM, Ha BJ, Heo MS, and Lee SH (2004) Establishment of in vitro test system for the evaluation of the estrogenic activities of natural products. Arch Pharm Res (NY) 27:906-911.
22. Kaku T, Miyata T, Uruno T, Sako I, and Kinoshita A (1975) Chemico-pharmacological studies on saponins of Panax ginseng C.A. Meyer. II. Pharmacological part. Arzneimittelforschung 25:539-547.
23. Kohn AD, Takeuchi F, and Roth RA (1996) Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. J Biol Chem 271:21920-21926.
24. Kone BC (2000) Protein-protein interactions controlling nitric oxide synthases. Acta Physiol Scand 168:27-31.
25. Kousteni S, Chen JR, Bellido T, Han L, Ali AA, O'Brien CA, Plotkin L, Fu O, Mancino AT, Wen Y, et al. (2002) Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science (Wash DC) 298:843-846.
26. Kropotov AV, Kolodnyak OL, and Koldaev VM (2002) Effects of Siberian ginseng extract and ipriflavone on the development of glucocorticoid-induced osteoporosis. Bull Exp Biol Med 133:252-254.
27. Lee Y, Jin Y, Lim W, Ji S, Choi S, Jang S, and Lee S (2003) A ginsenoside-Rh1, a component of ginseng saponin, activates estrogen receptor in human breast carcinoma MCF-7 cells. J Steroid Biochem Mol Biol 84:463-468.
28. Lippman M, Bolan G, and Huff K (1976) The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 36:4595-4601.
29. Low Dog T (2005) Menopause: a review of botanical dietary supplements. Am J Med 118:98-108.
30. McCall TB, Feelisch M, Palmer RM, and Moncada S (1991) Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phargocytic cells. Br J Pharmacol 102:234-238.
31. Narayanan K and Griffith OW (1994) Synthesis of L-thiocitrulline, L-homothiocitrulline, and S-methyl-L-thiocitrulline: a new class of potent nitric oxide synthase inhibitors. J Med Chem 37:885-887.
32. Porter AC and Vaillancourt RR (1998) Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. Oncogene 17:1343-1352.
33. Punnonen R and Lukola A (1984) The effect of ginseng on serum total cholesterol, HDL-cholesterol and triglyceride levels in postmenopausal women. Asia Oceania J Obstet Gynaecol 10:399-401.
34. + currents. Pflueg Arch Eur J Physiol 420:180-186.
35. Sato M, Hida N, and Umezawa Y (2005) Imaging the nanomolar range of nitric oxide with an amplifier-coupled fluorescent indicator in living cells. Proc Natl Acad Sci USA 102:14515-14520.
36. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, and Greene GL (1998) The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95:927-937.
37. Weiss DJ and Gurpide E (1998) Non-genomic effects of estrogens and antiestrogens. J Steroid Biochem 31:671-676.
38. Winslow LC and Kroll DJ (1998) Herbs as medicines. Arch Intern Med 158:2192-2199.
39. Wymann MP and Pirola L (1998) Structure and function of phosphoinositide 3-kinases. Biochim Biophys Acta 1436:127-150.
40. Zheng Y-J, Furukawa T, Ogura T, Tajimi K, and Inagaki N (2002) M phase-specific expression and phosphorylation-dependent ubiquitination of the ClC-2 channel. J Biol Chem 277:32268-32273.